TotalMarketCap

Serina Therapeutics

SERNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$41.149 M

$1.62 -4.14%

Close of 6 Nov 2026

As of 6 Nov 2026, Serina Therapeutics (SER) has a market capitalization of $41.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$130.0K

#3560 by revenue

Earnings

-$19.2M

Loss-making

Shares outstanding

25,400,473

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #347Alterity TherapeuticsATHE$41.5M
  2. #348Actinium PharmaceuticalsATNM$41.2M
  3. #349Serina TherapeuticsSER$41.1M
  4. #350Hyperion DefiHYPD$39.8M
  5. #351Dogwood TherapeuticsDWTX$39.8M

What if Serina Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,111,667

Per share 686,214× higher

Bitcoin $1.53T

$60,150.38

Per share 37,130× higher

Apple $5.02T

$197,468.08

Per share 121,894× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Serina Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.